CHRU Tours Hopital Bretonneau

Tours 8 trials 2 recruiting

8 Registered trials

2 Currently recruiting

Organisation

CHRU Tours Hopital Bretonneau

Location

Tours, France

Identifier

ORL-000004441

Address

2 Tonnelle boulevard, 37000, France

Departments

Hématologie
Hematology
ICU
Infectious Diseases
Pneumology
Service de Pneumologie
Urologie

Clinical trials at this site (8)

Search interface

Open label phase II study evaluating the efficacy and safety of the combination of tagraxofusp and venetoclax in treatment-naive blastic pla… Recruiting

2024-511003-42-00 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASMS 4 2025-12-11
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
A Phase 2 Study of CAL101 in Patients with Idiopathic Pulmonary Fibrosis Ended

2024-518339-12-00 Idiopathic Pulmonary Fibrosis 4 2025-07-08
STUDY AGORA-1 / ALFA 2100: Phase 2 on the combinaison of Gemtuzumab Ozogamicin witk gilteritinib in adult patients with acute myeloid leukem… Ended

2023-504176-25-00 Acute Myeloid Leukemia 9 2024-08-08
PREVENE : Preemptive therapy with Venetoclax for high risk CLL stage A patients, a phase II trial of the FILO Ended

2024-513718-37-00 IGHV unmutated patients with high-risk stage A CLL feat 4 2024-08-01
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Respiratory tract infection 5 2016-02-19
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients Ended

2024-515171-35-00 Prostatic adenocarnicoma with high risk of recurrence 5 2011-07-06
A clinical study to test the safety and efficacy of GB1211 in combination with atezolizumab in patients with Non-Small Cell Lung Cancer (NSC… Ended

2024-514419-93-00 Study to investigate the safety and efficacy of GB1211 9 2022-05-19